Streetbeat News

Products Services

JBLU

JetBlue reported an improvement in its operational performance during the summer travel season, with on-time performance increasing by approximately ten points year-over-year.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 11:09 am

AAPL

Apple Inc. (NASDAQ:AAPL) is set to unveil its iPhone 16 lineup, with the iPhone 16 Pro offering several advantages over the standard model, including a larger display, improved camera, premium build, superior performance, better battery management, and exclusive color options.

Portfolio Pulse from Ananya Gairola

September 05, 2024 | 11:09 am

GRYP

Gryphon Digital Mining (NASDAQ:GRYP) has announced the acquisition of an ultra low-cost bitcoin mining operation and reported strong August bitcoin production. The company achieved a bitcoin efficiency of 22 BTC/EH and improved its hashrate by 8% compared to August 2023. Gryphon continues to focus on sustainable operations powered by zero-carbon hydro power.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 11:08 am

EYEN

Eyenovia's partner, Formosa Pharmaceutical, received a Taiwan export license for Clobetasol Propionate Ophthalmic Suspension 0.05%, enabling its shipment to the U.S.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 11:07 am

TRNR

Interactive Strength Inc. (NASDAQ:TRNR) has secured exclusive distribution rights and received an initial order for its CLMBR fitness equipment in Switzerland and Austria.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 11:07 am

CSTL

Castle Biosciences has published a new study in Future Oncology that supports the use of its DecisionDx-SCC test for guiding patient selection and decision-making in high-risk cutaneous squamous cell carcinoma cases.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 11:05 am

BRCC

KDP

Black Rifle Coffee has signed a long-term sales and distribution agreement with Keurig Dr Pepper for its new line of ready-to-drink energy beverages. KDP will distribute these products nationwide, enhancing retail availability and market share.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 11:04 am

RNAZ

TransCode Therapeutics has been awarded a $2 million grant from the National Institutes of Health (NIH) to support the clinical evaluation of its lead candidate. This funding will aid in advancing their research and development efforts.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 11:02 am

BTAI

BioXcel Therapeutics has started patient enrollment for its SERENITY Phase 3 trial of BXCL501, targeting agitation in bipolar disorder and schizophrenia patients in an at-home setting. The trial is expected to last 9 to 12 months.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 11:02 am

TALO

Talos Energy announced a successful oil and gas discovery at its Ewing Bank 953 well and participation in the Sebastian prospect in the Gulf of Mexico. The EW 953 well has an estimated resource potential of 15-25 MMBoe, with production expected by mid-2026. The Sebastian prospect, currently drilling, targets a potential of 9-16 MMBoe, with results expected by late 2024.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 10:59 am